Enlitic Stock
Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.
Sign up today and learn more about Enlitic Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Enlitic Stock
Enlitic Inc. is a pioneer in medical deep learning that leverages proprietary algorithms to quickly and accurately improve healthcare diagnosis. With a platform developed by renowned data scientists, machine learning practitioners, and medical experts, Enlitic is able to analyze a wide variety of healthcare data sources, including billions of clinical cases, to improve diagnostic accuracy, speed and patient outcomes, as well as accelerate pharmaceutical research and drug trials. Named one of the world’s “50 Smartest Companies” by MIT Tech Review, Enlitic is based San Francisco and serves customers around the world.
Funding History
October 2014 | $5.0M |
---|---|
October 2015 | $10.0M |
April 2019 | $15.0M |
Management
Chief Executive Officer
Kevin Lyman
Head of Product, Marketing & Strategy
Vanessa Sawyer
Press
marketindex - Mar, 2 2024
Enlitic raising $35m to tackle US$3.7bn healthcare AI marketsharecafe - Feb, 19 2024
AI healthcare company Enlitic to list on ASXglobenewswire - Feb, 1 2024
Enlitic® Announces Appointment of Steve Rankin as Chief Strategy Officerretailbankerinternational - Jan, 20 2024
Who are the leading innovators in algorithmic trading for the ...dotmed - Jan, 20 2024
Private equity-backed LucidHealth sees continued growth ...